Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Australian Stock Exchange  >  Pro Medicus Limited    PME   AU000000PME8

PRO MEDICUS LIMITED

(PME)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
10/23/2020 10/26/2020 10/27/2020 10/28/2020 10/29/2020 Date
33.63 33.49 32.69 33.27 32.92 Last
308779 232829 306083 211798 239392 Volume
-1.44% -0.42% -2.39% +1.77% -1.05% Change
Financials
Sales 2021 69,5 M 48,9 M 48,9 M
Net income 2021 29,6 M 20,8 M 20,8 M
Net cash position 2021 60,1 M 42,3 M 42,3 M
P/E ratio 2021 116x
Yield 2021 0,44%
Sales 2022 85,7 M 60,3 M 60,3 M
Net income 2022 37,5 M 26,4 M 26,4 M
Net cash position 2022 78,3 M 55,1 M 55,1 M
P/E ratio 2022 91,1x
Yield 2022 0,54%
Capitalization 3 431 M 2 406 M 2 414 M
EV / Sales 2021 48,5x
EV / Sales 2022 39,1x
Nbr of Employees -
Free-Float 41,6%
More Financials
Company
Pro Medicus Ltd is an Australia-based company that provides health imaging information technology (IT). The Company provides a range of health imaging software and services to hospitals, imaging centers and health care groups. It offers its solutions under the brand, Visage. Its segments include Australia, Europe and North America. The Visage product line comprises solutions for radiology information systems... 
More about the company
Notations Surperformance© of Pro Medicus Limited
Trading Rating : Investor Rating :
More Ratings
All news about PRO MEDICUS LIMITED
10/15PRO MEDICUS : Morgans rates PME as Add
AQ
10/15PRO MEDICUS : PME Signs A$10M – 7 Year Contract with Munich based Ludwig-M..
PU
09/10PRO MEDICUS : PME Signs Research Collaboration Agreement with NYU Langone Health
PU
09/10PRO MEDICUS : PME Signs A$25M – 7 Year Contract with NYU Langone Health
PU
09/10PRO MEDICUS LIMITED : Ex-dividend day for final dividend
FA
08/19PRO MEDICUS : Full-Year Results
PU
07/30PRO MEDICUS : Appoints Deena Shiff as Director
PU
05/31PRO MEDICUS : signs A$22M – 5-year contract with Northwestern Memorial Hea..
PU
03/22Morgans rates SHL as Add
AQ
03/05PRO MEDICUS LIMITED : Ex-dividend day for interim dividend
FA
02/17PRO MEDICUS : Moving On New Revenue Streams
AQ
02/13PRO MEDICUS : Morgans rates PME as Add
AQ
2019PRO MEDICUS LIMITED : Ex-dividend day for final dividend
FA
2019PRO MEDICUS LIMITED : Ex-dividend day for extraordinary dividend
FA
2019PRO MEDICUS LIMITED : Ex-dividend day for interim dividend
FA
More news
News in other languages on PRO MEDICUS LIMITED

- No features available -

More news
Chart PRO MEDICUS LIMITED
Duration : Period :
Pro Medicus Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PRO MEDICUS LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Average target price 29,08 AUD
Last Close Price 32,92 AUD
Spread / Highest target 3,28%
Spread / Average Target -11,7%
Spread / Lowest Target -30,0%
EPS Revisions
Managers
NameTitle
Sam Aaron Hupert Chief Executive Officer, Executive Director& MD
Peter Terence Kempen Chairman
Clayton James Hatch Chief Financial Officer & Secretary
Anthony Barry Hall Executive Director & Director-Technology
Malte Westerhoff Global Chief Technology Officer & GM-Europe
Sector and Competitors
1st jan.Capitalization (M$)
PRO MEDICUS LIMITED47.29%2 449
VEEVA SYSTEMS INC.102.39%43 328
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED130.00%36 944
OMNICELL, INC.8.60%3 679
B-SOFT CO.,LTD.12.88%2 355
SECTRA AB (PUBL)36.57%2 325